eJHaem (Feb 2021)
First reported case of safe and efficacious use of tocilizumab for treatment of hyperinflammatory syndrome associated with COVID‐19 in an allogeneic stem cell transplant patient
Abstract
No abstracts available.
eJHaem (Feb 2021)